Development Group
News
The survey results are in – worst-case conditions for viral clearance
Accelerating industry progress with the new BioPhorum Council
How to predict, optimize and analyze high-concentration biologic therapeutic formulations
Everything you need to know about ‘ready to use’ cells … on a poster
BioPhorum’s Deliverables Report 2022 – all our content at your fingertips
How to maximize business value from process analytical technologies
How to make in-use stability and compatibility studies a success
BioPhorum’s Deliverables Report 2021 – all of our content at your fingertips
Formulation team sweeps away barriers to sharing
Speed to Clinic initiative launches: learning from the COVID-19 pandemic
LONG READSpeed to Clinic initiative launches: learning from the COVID-19 pandemic Spurred on by lessons learned from...
How to create a toolbox to assess your high-risk HCPs
BioPhorum launch new sustainability phorum
The survey results are in – worst-case conditions for viral clearance
Accelerating industry progress with the new BioPhorum Council
How to predict, optimize and analyze high-concentration biologic therapeutic formulations
Everything you need to know about ‘ready to use’ cells … on a poster
BioPhorum’s Deliverables Report 2022 – all our content at your fingertips
How to maximize business value from process analytical technologies
How to make in-use stability and compatibility studies a success
BioPhorum’s Deliverables Report 2021 – all of our content at your fingertips
Formulation team sweeps away barriers to sharing
Speed to Clinic initiative launches: learning from the COVID-19 pandemic
LONG READSpeed to Clinic initiative launches: learning from the COVID-19 pandemic Spurred on by lessons learned from...
How to create a toolbox to assess your high-risk HCPs
BioPhorum launch new sustainability phorum
Chain reaction: how the biopharmaceutical supply chain survived the pandemic
LONG READChain reaction: how the biopharmaceutical supply chain survived the pandemicThe pressure on the...